This is a Validated Antibody Database (VAD) review about human CXCR3, based on 47 published articles (read how Labome selects the articles), using CXCR3 antibody in all methods. It is aimed to help Labome visitors find the most suited CXCR3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CXCR3 synonym: CD182; CD183; CKR-L2; CMKAR3; GPR9; IP10-R; Mig-R; MigR; C-X-C chemokine receptor type 3; G protein-coupled receptor 9; IP-10 receptor; Mig receptor; chemokine (C-X-C motif) receptor 3; chemokine receptor 3; interferon-inducible protein 10 receptor

BioLegend
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CXCR3 antibody (BioLegend, GO25H7) was used in flow cytometry on human samples (fig 5a). PLoS ONE (2017) ncbi
mouse monoclonal (G025H7)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CXCR3 antibody (Biolegend, G025H7) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CXCR3 antibody (BioLegend, G025H7) was used in flow cytometry on human samples (fig 2b). Sci Rep (2017) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; fig 7b
BioLegend CXCR3 antibody (BioLegend, G025H7) was used in flow cytometry on human samples (fig 7b). elife (2017) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 2a
In order to map the lineage of human dendritic cells, BioLegend CXCR3 antibody (BioLegend, G025H7) was used in flow cytometry on human samples (fig 2a). Science (2017) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig s3c
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BioLegend CXCR3 antibody (BioLegend, G025H7) was used in flow cytometry on human samples (fig s3c). J Clin Invest (2017) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CXCR3 antibody (BioLegend, G025H7) was used in flow cytometry on human samples (fig s1a). JCI Insight (2017) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 2b
In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, BioLegend CXCR3 antibody (Biolegend, G02SH7) was used in flow cytometry on human samples (fig 2b). Genome Med (2017) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 5b
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BioLegend CXCR3 antibody (Biolegend, 353716) was used in flow cytometry on human samples (fig 5b). Sci Rep (2017) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 2a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CXCR3 antibody (Biolegend, G025H7) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CXCR3 antibody (Biolegend, G025H7) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig s2d
BioLegend CXCR3 antibody (BioLegend, G025H7) was used in flow cytometry on human samples (fig s2d). J Immunol (2016) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CXCR3 antibody (BioLegend, G025H7) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; fig 1
BioLegend CXCR3 antibody (Biolegend, G025H7) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 1a
  • flow cytometry; scFv; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CXCR3 antibody (biolegend, G025H7) was used in flow cytometry on human samples (fig 1a) and in flow cytometry on scFv samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; loading ...; fig 7a
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BioLegend CXCR3 antibody (BioLegend, G025H7) was used in flow cytometry on human samples (fig 7a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend CXCR3 antibody (Biolegend, G025H7) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (G025H7)
  • flow cytometry; human; fig 3
BioLegend CXCR3 antibody (Biolegend, G025H7) was used in flow cytometry on human samples (fig 3). Clin Cancer Res (2015) ncbi
mouse monoclonal (G025H7)
BioLegend CXCR3 antibody (BioLegend, G025H7) was used . Clin Cancer Res (2014) ncbi
R&D Systems
mouse monoclonal (49801)
  • flow cytometry; human; loading ...; fig 3a
In order to study the expression of CCR10 and CXCR3 in circulating CD8 T cells specific for human herpes simplex virus, R&D Systems CXCR3 antibody (R&D, 49801) was used in flow cytometry on human samples (fig 3a). J Virol (2017) ncbi
mouse monoclonal (49801)
  • flow cytometry; human; fig 4
In order to investigate lactam-specific T-cell response in the skin and blood of humans, R&D Systems CXCR3 antibody (R&D Systems, 49801) was used in flow cytometry on human samples (fig 4). J Allergy Clin Immunol (2018) ncbi
LifeSpan Biosciences
mouse monoclonal (2AR1)
  • blocking or activating experiments; human
LifeSpan Biosciences CXCR3 antibody (LifeSpan, LS-C6283-500) was used in blocking or activating experiments on human samples . Nat Commun (2015) ncbi
mouse monoclonal (2AR1)
  • immunohistochemistry - paraffin section; human; 1:20000
LifeSpan Biosciences CXCR3 antibody (LifeSpan Biosciences, LS-C6283) was used in immunohistochemistry - paraffin section on human samples at 1:20000. J Clin Oncol (2010) ncbi
Abcam
mouse monoclonal (49801)
  • immunohistochemistry - paraffin section; human; 0.5 ug/ml
Abcam CXCR3 antibody (Abcam, ab64714) was used in immunohistochemistry - paraffin section on human samples at 0.5 ug/ml. Br J Cancer (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:150
  • western blot; human; 1:1000
Abcam CXCR3 antibody (Abcam, ab71864) was used in immunohistochemistry on human samples at 1:150 and in western blot on human samples at 1:1000. J Clin Immunol (2013) ncbi
Proteintech Group
mouse monoclonal (1B2D6)
  • western blot; human; 1:1000; loading ...; fig 5b
Proteintech Group CXCR3 antibody (Proteintech, 60065-1-1g) was used in western blot on human samples at 1:1000 (fig 5b). Hum Pathol (2015) ncbi
Invitrogen
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100
In order to measure CXCR3 ligands in the serum of renal allograft recipients, Invitrogen CXCR3 antibody (Thermo Fisher Scientific, PA1-32503) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mol Med Rep (2014) ncbi
BD Biosciences
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences CXCR3 antibody (BD, 560832) was used in flow cytometry on human samples (fig 3d). J Clin Invest (2018) ncbi
mouse monoclonal (6C6)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CXCR3 antibody (BD Pharmigen, 6C6) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2018) ncbi
mouse monoclonal (6C6)
  • flow cytometry; human; fig 1
BD Biosciences CXCR3 antibody (BD Biosciences, 555933) was used in flow cytometry on human samples (fig 1). J Cell Physiol (2017) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; fig 1
BD Biosciences CXCR3 antibody (BD Biosciences, 557185) was used in flow cytometry on human samples (fig 1). J Cell Physiol (2017) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CXCR3 antibody (BD Pharmingen, 560831) was used in flow cytometry on human samples (fig 1b). Sci Rep (2017) ncbi
mouse monoclonal (6D4/D6/G2)
  • flow cytometry; human; loading ...; fig 5c
In order to study the effect of LL37 peptide in the immune over-activation of Behcet's disease., BD Biosciences CXCR3 antibody (BD, 555048) was used in flow cytometry on human samples (fig 5c). J Extracell Vesicles (2017) ncbi
mouse monoclonal (6C6)
  • flow cytometry; human
BD Biosciences CXCR3 antibody (BD Bioscience, 6C6) was used in flow cytometry on human samples . Int J Cancer (2017) ncbi
mouse monoclonal (6C6)
  • flow cytometry; human; 1:5; fig 5
  • immunocytochemistry; human; loading ...; fig 6
BD Biosciences CXCR3 antibody (BD Bioscience, 555933) was used in flow cytometry on human samples at 1:5 (fig 5) and in immunocytochemistry on human samples (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; loading ...; fig 1c
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, BD Biosciences CXCR3 antibody (BD, 1C6/CXCR3) was used in flow cytometry on human samples (fig 1c). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; loading ...; fig 2a
In order to characterize B cells and antibody repertoires from injection drug users, BD Biosciences CXCR3 antibody (BD, 1C6/CXCR3) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2016) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; Rhesus monkey; 1:50
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BD Biosciences CXCR3 antibody (BD Biosciences, 562451) was used in flow cytometry on Rhesus monkey samples at 1:50. Nat Med (2016) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; loading ...; fig 5d
BD Biosciences CXCR3 antibody (BD Biosciences, 1C6/CXCR3) was used in flow cytometry on human samples (fig 5d). J Immunol (2016) ncbi
mouse monoclonal (6C6)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CXCR3 antibody (BD, 555933) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CXCR3 antibody (BD, 557185) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (1C6/CXCR3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
In order to determine the effects of PD-0360324, a fully human immunoglobulin G2 monoclonal antibody against macrophage colony-stimulating factor, in patients with cutaneous lupus erythematosus, BD Biosciences CXCR3 antibody (BD Biosciences, 557183) was used in immunohistochemistry - paraffin section on human samples (fig 6a). Clin Exp Immunol (2016) ncbi
mouse monoclonal (6C6)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BD Biosciences CXCR3 antibody (BD Pharmingen, 551126) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; loading ...; fig 2b,2e
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BD Biosciences CXCR3 antibody (BD, 561320) was used in flow cytometry on human samples (fig 2b,2e). PLoS Pathog (2015) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human
BD Biosciences CXCR3 antibody (BD Biosciences, 1C6/CXCR3) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; tbl 2
In order to test if flow cytometry can be used to find mantle cell lymphoma, BD Biosciences CXCR3 antibody (BD Bioscience, 1C6/CXR3) was used in flow cytometry on human samples (tbl 2). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human
BD Biosciences CXCR3 antibody (BD Biosciences, 1C6/CXCR3) was used in flow cytometry on human samples . Cytotherapy (2015) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), BD Biosciences CXCR3 antibody (BD, 1c6/CXCR3) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (1C6/CXCR3)
  • flow cytometry; human; fig 3
BD Biosciences CXCR3 antibody (BD, 1C6/CXCR3) was used in flow cytometry on human samples (fig 3). Ann Rheum Dis (2014) ncbi
Articles Reviewed
  1. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  2. Armas González E, Domínguez Luis M, Díaz Martín A, Arce Franco M, Castro Hernandez J, Danelon G, et al. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis. Arthritis Res Ther. 2018;20:114 pubmed publisher
  3. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed publisher
  4. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed publisher
  5. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  6. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed publisher
  7. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed publisher
  8. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  9. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  10. Buskermolen J, Roffel S, Gibbs S. Stimulation of oral fibroblast chemokine receptors identifies CCR3 and CCR4 as potential wound healing targets. J Cell Physiol. 2017;232:2996-3005 pubmed publisher
  11. Singh A, Subhi Y, Krogh Nielsen M, Falk M, Matzen S, Sellebjerg F, et al. Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study. Sci Rep. 2017;7:605 pubmed publisher
  12. Kahraman T, Gucluler G, Simsek I, Yagci F, Yildirim M, Ozen C, et al. Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severity. J Extracell Vesicles. 2017;6:1284449 pubmed publisher
  13. Millrud C, Kågedal A, Kumlien Georén S, Winqvist O, Uddman R, Razavi R, et al. NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC. Int J Cancer. 2017;140:2557-2567 pubmed publisher
  14. Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, et al. ?-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells. J Allergy Clin Immunol. 2018;141:235-249.e8 pubmed publisher
  15. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed publisher
  16. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed publisher
  17. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  18. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  19. Wang X, Qin W, Zhang Y, Zhang H, Sun B. Endotoxin promotes neutrophil hierarchical chemotaxis via the p38-membrane receptor pathway. Oncotarget. 2016;7:74247-74258 pubmed publisher
  20. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  21. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  22. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  23. Kilcollins A, Li J, Hsiao C, Wiemer A. HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by V?9V?2 T Lymphocyte Effectors. J Immunol. 2016;197:419-28 pubmed publisher
  24. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  25. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  26. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  27. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  28. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  29. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  30. Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, et al. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer. Hum Pathol. 2015;46:1872-80 pubmed publisher
  31. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  32. Masek Hammerman K, Peeva E, Ahmad A, Menon S, Afsharvand M, Peng Qu R, et al. Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupu. Clin Exp Immunol. 2016;183:258-70 pubmed publisher
  33. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  34. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  35. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  36. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  37. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed publisher
  38. Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, et al. The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clin Cancer Res. 2015;21:2840-50 pubmed publisher
  39. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  40. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed publisher
  41. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed publisher
  42. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  43. Walters M, Ebsworth K, Berahovich R, Penfold M, Liu S, Al Omran R, et al. Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats. Br J Cancer. 2014;110:1179-88 pubmed publisher
  44. Huang H, Xu X, Yao C, Cai M, Qian Y, Wang X, et al. Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation. Mol Med Rep. 2014;9:45-50 pubmed publisher
  45. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed publisher
  46. Zhou S, Ma J, Qu H, Liu Z, He W, Wang J, et al. Characterization of Th1- and Th2-associated chemokine receptor expression in spleens of patients with immune thrombocytopenia. J Clin Immunol. 2013;33:938-46 pubmed publisher
  47. Denkert C, Loibl S, Noske A, Roller M, Müller B, Komor M, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010;28:105-13 pubmed publisher